Schering to buy NeoGenesis

01/21/2005 | Boston Globe (tiered subscription model), The

Schering-Plough said it plans to buy NeoGenesis Pharmaceuticals, an outgrowth of their previous "deep collaboration" on several antiviral drugs and other medicines. Terms of the deal were not disclosed, but Schering said it intends to use the merger to improve its own drug-discovery technology.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI